Engineering Conferences International

ECI Digital Archives
Single-Use Technologies III: Scientific and
Technological Advancements

Proceedings

9-23-2018

Purity testing protocols for silicone tubing
Csilla Kollar
Dow Silicones Corporation, USA, csilla.kollar@dowcorning.com

Lise Tan-Sien-Hee
Dow Silicones Corporation, Seneffe, Belgium

Follow this and additional works at: http://dc.engconfintl.org/sut_iii
Part of the Engineering Commons
Recommended Citation
Csilla Kollar and Lise Tan-Sien-Hee, "Purity testing protocols for silicone tubing" in "Single-Use Technologies III: Scientific and
Technological Advancements", Weibing Ding, Amgen Martina Micheletti, University College London Robert Repetto, Pfizer Eds, ECI
Symposium Series, (2018). http://dc.engconfintl.org/sut_iii/35

This Abstract and Presentation is brought to you for free and open access by the Proceedings at ECI Digital Archives. It has been accepted for inclusion
in Single-Use Technologies III: Scientific and Technological Advancements by an authorized administrator of ECI Digital Archives. For more
information, please contact franco@bepress.com.

ECI Single-Use Technologies III:
Scientific and Technological Advancements
September 23, 2018
Snowbird, Utah

Purity Testing Protocols for Silicone Tubing
Lise Tan-Sien-Hee and Csilla Kollar |

|

Technical Service & Development

Dow Silicones Corporation

INTRODUCTION

ISO 11737-1 BIOBURDEN TEST

USP <788> PARTICULATE MATTER IN INJECTIONS

Silicone tubing is widely used for fluid transfer in critical biopharmaceutical processes that require
high-purity product-contact single-use components. For drug product safety, the risk for particulate,
endotoxin and microorganism contaminations must be evaluated. The industry standards applied
for purity testing were originally intended for drug product packaging and for medical devices;
consequently, their implementation is not well-defined for single-use components and systems. In
this poster presentation, we describe the developmental work completed for sample preparation and
implementation of the protocols for the ISO and USP tests.

Sterilization of medical devices – Microbiological methods
Part 1: Determination of a population of microorganisms on products
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Light Obscuration
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•

Tubing sizes ranged from: 0.125" to 0.750" (ID).

MATERIAL AND MANUFACTURING IMPACT
Platinum-Catalyzed Addition Cure: A Clean Chemistry

Results
•

No bioburden of any kind was detected for all products tested

USP <85> BACTERIAL ENDOTOXINS TEST

No processing aids
No organic plasticizers
No stabilizers
No by-products
Low extractables profile

SILASTIC™ biomedical-grade silicone elastomer is used to extrude the DOW CORNING™
Pharma Tubing family of products.
Vertical integration: Our vertically integrated supply chain allows control from starting materials
production to the tubing extrusion, and it provides traceability as well as quality control.

•
•
•

40 samples tested for each lot
Testing performed under internal method developed for medical device tubing
Gel clot method was selected for the detection of endotoxin
– Based on clotting of a limulus amebocyte lysate (LAL) reagent

•
•
•

The inner lumen of the tubing was extracted with pyrogen-free water
The tubing extract was exposed to LAL reagent with ≥0.125 EU/mL sensitivity
Acceptance criteria: Pass if no gel formation, meaning the LAL reagent does not react/clot with
extract that has <0.125 EU/mL

Results
•

All the silicone tubing batches tested pass the acceptance criteria of <0.125 EU/mL
– More stringent than USP <85> Water For Injection: 0.25 EU/mL
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Validation of the removal method:
– Validations were performed on both larger-bore (ID 5/8") and smaller-bore (ID 3/16") tubing
– Tubing samples were sterilized by gamma irradiation (≥25 kGy)
– The fluid path of the tubing was inoculated with a known concentration of Staphylococcus
aureus; recovery efficiency of the microorganisms was determined and compared with the
reference inoculum suspension to establish the correction factor
Enumeration technique:
– The inner lumen of the tubing was flushed under aseptic conditions (LAF Class 5) to remove
the microorganisms and the eluent was filtered through a membrane; the filter was then
transferred onto agar for incubation
– Counts for total aerobic bacteria, yeast, molds and spores were determined by multiplying the
number of counted colonies on the plate with the correction factor
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Method 1 vs. Method 2

Procedure

TESTED PRODUCTS
Tubing Type

•
•

The most comprehensive test method was selected and plate count technique was used for total
aerobic bacteria, yeast, molds and spores
12 lots were tested in triplicate
Testing involved large fluid contact surface area of tubing samples
– 15-meter coils with ID up to 0.625"

Subvisible particulates testing per USP <788> is originally intended for packaged drugs
Method 1: Light Obscuration Particulate Count Test – enumerates liquid and solid particles and gas
bubbles; detected liquid particulates may be related to extractables
Method 2: Microscopic Particulate Count Test – only enumerates solid particulates; solid
particulates are the most concerning
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<1% of total particulates counted by LO are solids
Minimal particulates ≥25μm
(<0.15 particulates/ml by both methods)

Method 2 testing
•
•
•

19 lots of tubing were tested in triplicate
Particulates were extracted from inner lumen of the tubing with PFW
Extract volume was collected after multiple inversions of the tubing samples and filtered
on membrane for counting
USP 788 criteria for Method 2:
<12/mL for particulates ≥10µm
<2/mL for particulates ≥25µm

Results
•

Minimal amount of solid particulates found in tested samples:
<0.6 particulate/mL (≥10 µm size)
<0.2 particulate/mL (≥25 µm size)

CONCLUSION
•
•
•
•

Industry standards currently applied for purity testing of single-use components were originally
developed for medical devices and drug product packaging; therefore, more applicable methods
have been developed
A large number of samples and multiple tubing sizes were tested to support our sample preparation
and protocol development process
The study was designed to address the worst-case scenario conditions for method development
The bioburden endotoxin and particulate testing results support the high level of purity of the tested
DOW CORNING™ Pharma Tubing silicone products
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